An Introduction to Medical Device Software: Regulations & Requirements to include EU & FDA Guidance and Risk Management
20-21 Nov 2018
& 1-2 May 2019
GBP 1,499 1,299 *
EUR 2,099 1,819 *
USD 2,338 2,026 *
* When you book before 5 Oct
This course will provide a comprehensive introduction to the regulations and requirements that apply to medical device software wordwide. The seminar will be highly interactive, using real life examples and state-of-the-art practices. You will learn how to prepare compliant technical files and 510(k)s for medical device software products and get insight into state-of-the-art standards and FDA guidance applicable to software.
Day two of the course goes more in depth. It provides for a thorough understanding on the practical implementation of the standards and guidance applicable to software. Practical experience is shared and common pitfalls identified for establishing and maintaining compliant processes for design control, risk management, usability engineering, verification and validation
and clinical evaluations for software.
BENEFITS OF ATTENDING:
Laws and regulations A software perspective
Introduction to the regulations
Medical device software qualification and classification
Software classification – EU
Software classification case studies – EU
Classification according to the FDA
Bringing medical device software on the EU market
Notified Bodies and the evidence they consider
Practical construction of a technical file
EUDAMED registration and distribution chain responsibilities
On the market
End of day one
Laws and regulations – A software perspective cont.
Bringing medical software on the US market
Rest of the World (Brazil, Canada etc.)
Standards and their implementation – A software perspective
Standards
Fundamental principles design control
Design activities in detail
End of course
Peter Pringle
Peter Pringle is a consultant with international hospital experience; he has managed projects in installation, process and software. His medical software experience brings a unique understanding of the quality systems and configuration control that is required to make a project right first time.
He has the ability to focus and create a vision, interact and motivate at all levels while not afraid of confutation and accepting responsibilities. He enjoys the challenge of empowering people to be accountable for their tasks bringing about the ability to see the big picture in a very short space of time.
Since May 2000 he has operated as an independent (Accredited Business Link & MHRA) consultant. He has established an expertise in developing project proposals and stimulating co-maker and e-business relationships with many companies, also developing and submitting major project proposals for several clients with considerable success. From 1986 to 2000 he worked in the Radiotherapy division of Philips Medical Systems (purchased by Elekta of Sweden) whose main products consist of a range of computer controlled linear accelerators for the treatment of cancer.
He has worked extensively in Scandinavia, Germany, Italy, Russia, USA and Great Britain. With this experience he can bring a very personal view of project processes, interpretation and implementation to any forum, together with a unique ability to focus a team on the objectives and goals that are required by the sponsor of the project.
Peter is qualified in ISO 13485 / 9000 / 14000 / 14971 and prepares FDA pre audits, establishing technical documentation for product compliance to the Medical Device Directive, he also advises companies on software development procedures and documentation.
Koen Cobbaert
Koen Cobbaert is chair of COCIR’s software task force, COCIR is the European Trade Association representing the medical imaging, radiotherapy, health ICT and electromedical industries. In that role he co-authored the first and second edition of MEDDEV 2.1/6 on the qualification and classification of standalone software and is today co-authoring the software classification guidance for Rule 10 and 11 under the Medical Device Regulation. In that role Koen also co-authored the FAQ on 62304:2006. In his day to day job Koen works for Agfa Healthcare as regulatory affairs and quality assurance professional in the development of software applications for use in general radiology, nuclear medicine, cardiology and orthopaedics. He has submitted a variety of technical files and 510(k)s for software-only medical devices. He guards process compliance for solution development processes and is himself responsible for managing Agfa’s risk management, clinical evaluation and regulatory monitoring process. Koen has a master in electrical engineering and risk management.| 20-21 Nov 2018 | ||||
| 20-21 Nov 2018 | Cavendish Hotel, London | GBP 1,499.00 EUR 2,099.00 USD 2,338.00 + VAT @ 20.00% |
GBP 1,299.00 EUR 1,819.00 USD 2,026.00 Until 5 Oct |
Enrol now |
| 1-2 May 2019 | ||||
| 1-2 May 2019 | Cavendish Hotel, London | GBP 1,499.00 EUR 2,099.00 USD 2,338.00 + VAT @ 20.00% |
Enrol now | |
.jpg)
“Good course. A lot of information in detail.”
Jose Fernandez, Certification Manager, McLaren
“A well structured, well presented programme”
Peter Ogrodnik, Professor of Biomedical Engineering, Keele University
“It was great that both speakers had an understanding of what devices IBA makes and they tried to give suitable answers for our case”
Inez Wathion, Verification & Validation Officer, Ion Beam Applications SA
“Excellent content - good choice of speakers”
Malgorzata Wilinska, Research Associate, University of Cambridge
“Very good presentation”
Massimo Panonzini, , Inpeco SA
“Very good”
Robert Gay, Senior Regulatory Affairs Manager - External Products and Software, Cochlear Limited
“Very good, I would recommend this course for beginners and advanced levels”
Arnaud Biermann, Senior Manager Regulatory Affairs, Anteis SA
“The presentations in the folders did not follow the order that was presented by the speakers. Always best to check beforehand with the speakers the order of information as ideally it should match of presentation. This meant we were all looking for the slides whilst the speakers had started, meaning we often missed some important points.”
Priti Darjee, Associate Director Regulatory Affairs, UK, Teva UK Ltd